Search results
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 2 days agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 2 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Pfizer profits drop on lower Covid-19 product sales
AFP via Yahoo Finance· 2 days agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 2 days agoWhile the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed...
Pfizer Shares Jump After Beating Estimates
The Wall Street Journal· 2 days agoPfizer shares rose more than 6% Wednesday afternoon after the company's first-quarter results beat Wall Street analyst estimates and the drugmaker raised...
Pfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dose - Triangle Business...
The Business Journals· 5 days agoThe U.S. Food and Drug Administration has approved a gene therapy developed by Pfizer and...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
Pfizer Q1 earnings: non-Covid product sales help post revenues of $14.9 billion despite Comirnaty,...
Invezz· 2 days agoPfizer Inc. has announced its financial outcomes for the first quarter of 2024, displaying strong...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 2 days agoPfizer stock surged Wednesday after the pharma giant walloped analysts' first-quarter earnings...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 3 days agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...